Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Adrenal Cancer

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Adrenal Cancer in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Preston, GM1
White, BA1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Adrenal Cancer

ArticleYear
The intracellular calcium antagonist, TMB-8, inhibits prolactin gene expression in GH3 cells.
    Life sciences, 1987, Nov-16, Volume: 41, Issue:20

    Topics: Adrenal Gland Neoplasms; Animals; Calcium; Calcium Chloride; Cell Line; Gallic Acid; Gene Expression

1987